Add-on benefits of botulinum toxin type A in combination or sequential therapies for scar management: a systematic review and meta-analysis - Report - MDSpire
Advertisement
Add-on benefits of botulinum toxin type A in combination or sequential therapies for scar management: a systematic review and meta-analysis
Clinical Report: Evaluating the Additional Advantages of Botulinum Toxin Type A in Combination or Sequential Treatment Approaches for Scar Management
Overview
This systematic review and meta-analysis evaluates the efficacy of botulinum toxin type A (BoNT-A) as an adjunctive treatment in scar management. The findings suggest that BoNT-A may significantly improve scar appearance, although the evidence is of low certainty.
Background
Scarring is a common consequence of wound healing that can lead to functional impairment and psychological distress. Various treatment modalities exist, but outcomes are often variable, prompting the use of multimodal strategies. BoNT-A has emerged as a potential adjunctive therapy aimed at reducing mechanical tension on healing wounds, which is a key factor in pathological scar formation.
Data Highlights
Outcome Measure
Mean Difference (MD)
Vancouver Scar Scale (VSS)
-1.80
Stony Brook Scar Evaluation Scale (SBSES)
1.46
Key Findings
BoNT-A significantly improved scar appearance with a MD of -1.80 for VSS.
BoNT-A showed a MD of 1.46 for SBSES, indicating improved scar evaluation.
The evidence supporting BoNT-A's efficacy is classified as low-certainty.
Mechanical tension is a recognized contributor to pathological scar formation.
BoNT-A may facilitate more favorable scar maturation by reducing local muscle activity.
Clinical Implications
Clinicians should consider the potential adjunctive benefits of BoNT-A in scar management, particularly in cases where mechanical tension is a concern. However, treatment plans should remain individualized and cautious due to the low-certainty evidence.
Conclusion
While BoNT-A may offer benefits in scar management, further high-quality, standardized randomized controlled trials are necessary to confirm these findings.
